RESVIQ
LIVE

Serial Number

97076937

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Oct 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

RESVIQ Trademark

Serial Number: 97076937 • Registration: 7504958

RESVIQ is a trademark filed by GlaxoSmithKline Biologicals SA on October 15, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

October 15, 2021

Registration Date

September 17, 2024

Published for Opposition

June 25, 2024

Goods & Services

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2024 R.PR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Aug 8, 2024 ERRR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 25, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 25, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 5, 2024 NONP
CASE RETURNED TO EXAMINATION
May 22, 2024 OTHE
NOTICE OF ALLOWANCE CANCELLED
May 22, 2024 IUCN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 10, 2024 EXRA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 9, 2024 JURT
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
May 9, 2024 PCBG
ASSIGNED TO PETITION STAFF
May 9, 2024 APET
SOU EXTENSION 3 GRANTED
May 9, 2024 EX3G
NOTICE OF REVIVAL - E-MAILED
May 9, 2024 NREV
PETITION GRANTED - EXTENSION REQUEST FILED
May 9, 2024 PGEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
May 8, 2024 TPEX
PETITION INQUIRY LETTER ISSUED
May 7, 2024 PILM
TEAS RESPONSE TO PETITION INQUIRY LETTER
May 7, 2024 ERTI
PETITION INQUIRY LETTER ISSUED
May 1, 2024 PILM
ASSIGNED TO PETITION STAFF
Apr 29, 2024 APET
SOU EXTENSION 3 FILED
Apr 18, 2024 EXT3
PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Mar 29, 2024 PDCB
TEAS PETITION TO AMEND BASIS RECEIVED
Mar 29, 2024 TPAD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 22, 2023 EXRA
SOU EXTENSION 2 GRANTED
Sep 20, 2023 EX2G
SOU EXTENSION 2 FILED
Sep 20, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 20, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 18, 2023 EXRA
SOU EXTENSION 1 GRANTED
Apr 14, 2023 EX1G
SOU EXTENSION 1 FILED
Apr 14, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 14, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 18, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 23, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 23, 2022 PUBO
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 3, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 3, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 3, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 3, 2022 REAP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 3, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jul 20, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 15, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 8, 2022 CNSA
ASSIGNED TO EXAMINER
Jun 29, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2021 NWOS
NEW APPLICATION ENTERED
Oct 19, 2021 NWAP